Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,147
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: New Haven CT, New York NY, Hackensack NJ, Morristown NJ,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: New Haven CT, Pittsburgh PA, Dallas TX, Duarte CA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, New Brunswick NJ, Boston MA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia
for
Hypovolemia, Hemodynamic Instability
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 20 - 45
Code: NCT03592290
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
for
Nicotine Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05932745
Recruiting
OMAR Opioid Use Disorder
for
Healthy Control, Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05683184
Phase1, Recruiting
Toward a Computationally-Informed, Personalized Treatment for Hallucinations
for
Hallucinations, Auditory, Psychosis
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT04366518
Early_phase1, Recruiting
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
for
Alcohol Consumption, Heavy Drinker, Alcohol Use Disorder (AUD)
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 21 - 50
Code: NCT06136195
Phase1, Recruiting
SV2A in Older Adults
for
Cannabis Use
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 50+
Code: NCT05465538
Phase1, Phase2, Recruiting
Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
for
Borderline Personality Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 60
Code: NCT06446765
Phase2, Recruiting
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
for
Schizophrenia, Cannabis Dependence,
Location: New Haven CT
Sponsor: Yale University
Sex: Male
Age: 18 - 55
Code: NCT01730781
Recruiting
Combined THC and CBD for OUD and Chronic Pain
for
Chronic Pain, Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT06544291
Phase2, Recruiting
Opioid Use Disorder and Pain
for
Opioid Use Disorder,
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 21 - 60
Code: NCT06800703
Recruiting
Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder
for
Alcohol Use Disorder
Location: New Haven CT
Sponsor: Newleos Therapeutics, Inc.
Sex: All
Age: 21 - 60
Code: NCT07520292
Phase1, Recruiting
A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
for
Alcohol Use Disorder
Location: New Haven CT, Baltimore MD
Sponsor: Clearmind Medicine Inc.
Sex: All
Age: 18 - 60
Code: NCT05913752
Phase1, Phase2, Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
for
Clinical High Risk for Psychosis (CHR)
Location: New Haven CT, Glen Oaks NY, New York NY, Boston MA,